The effect of olanzapine on craving and alcohol consumption.

Kent E Hutchison, Lara Ray, Erica Sandman, Marie-Christine Rutter, Annie Peters, Dena Davidson, Robert Swift

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006 Jun

filter terms:

Previous studies have indicated that olanzapine decreases craving after a priming dose of alcohol, that craving after a priming dose of alcohol is greater among individuals with the seven-repeat allele of the DRD4 variable number of tandem repeats (VNTR) polymorphism, and that the effect of olanzapine (a D2/D4 antagonist) is more pronounced among individuals with this allele. The present study tested the hypothesis that olanzapine may be differentially effective at reducing cue-elicited craving and differentially effective as a treatment for alcohol dependence over the course of a 12-week, randomized, placebo-controlled trial among individuals with and without the seven-repeat allele. Participants who met DSM IV criteria for alcohol dependence were randomly assigned to receive olanzapine (5 mg) or a placebo over the course of the trial. After 2 weeks of treatment, participants completed a cue reactivity assessment. The results suggested that participants who were homozygous or heterozygous for the seven (or longer)-repeat allele of the DRD4 VNTR responded to olanzapine with reductions in cue-elicited craving as well as reductions in alcohol consumption over the course of the 12-week trial, whereas individuals with the shorter alleles did not respond favorably to olanzapine.

Citation

Kent E Hutchison, Lara Ray, Erica Sandman, Marie-Christine Rutter, Annie Peters, Dena Davidson, Robert Swift. The effect of olanzapine on craving and alcohol consumption. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2006 Jun;31(6):1310-7